Mucormycosis: A 10-year experience at a tertiary care center in Turkey

Turkish Journal of Medical Sciences

Volumn 46, Issue 1, 2016, Pages 58-62

  Kömür, Süheyla ^a   İnal, Ayşe Seza ^a   Kurtaran, Behice ^a   Ulu, Aslıhan ^a   Uğuz, Aysun ^a   Aksu, Hasan Salih Zeki ^a   Taşova, Yeşim ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Facial pain; Fever; Liposomal amphotericin; Mucormycosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FACE EDEMA; FACE PAIN; FEMALE; FEVER; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KETOACIDOSIS; MAJOR CLINICAL STUDY; MALE; MUCORMYCOSIS; NOSE MUCOSA; RHINORRHEA; RISK FACTOR; TERTIARY CARE CENTER; UNCONSCIOUSNESS; IMMUNOCOMPROMISED PATIENT; MIDDLE AGED; TURKEY (BIRD);

ANTIFUNGAL AGENT;

ADULT; ANTIFUNGAL AGENTS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MUCORMYCOSIS; TERTIARY CARE CENTERS; TURKEY;

EID: 84953774803     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1409-137     Document Type: Article

References (25)

1. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012; 54 (Suppl. 1): 23–34.
2. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634–653.
3. Rogers TR. Treatment of zygomycosis: current and new options. J Antimicrob Chemother 2008; 61: i35–i39.
4. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48: 1743–1751.
5. Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrau K, Lass-Florl C, Bouza E, Klimko N, Gaustad P et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011; 17: 1859–1867.
6. Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, Desenclos JC, Lortholary O. Increasing incidence of zygomycosis (mucormycosis), France. Emerg Infect Dis 2005; 41: 634–653.
7. Ambrosioni J, Bouchuiguir-Wafa K, Garbino J. Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. Int J Inf Dis 2010; 14: 100–103.
8. Kara O, Tasova Y, Uguz A, Sahin B. Mucormycosis-associated fungal infections in patients with haematological malignancies. Int J Clin Prac 2009; 63: 134–139.
9. Arda B, Erdem A, Sipahi OR, Işıkgöz Taşbakan M, Pullukçu H, Taşbakan MS, Ceylan N, Metin DY, Midilli R, Yamazhan T et al. Mucormycosis: a retrospective evaluation of 12 cases. Mikrobiyol Bul 2011; 45: 504–511.
10. Ketenci I, Unlu Y, Kaya H, Somdaş MA, Kontaş O, Öztürk M, Vural A. Rhinocerebral mucormycosis: experience in 14 patients. J Laryngol Otol 2011; 125: 1–9.
11. Zeka AN, Taşbakan M, Pullukçu H, Sipahi OR, Yamazhan T, Arda B. Evaluation of zygomycosis cases by pooled analysis method reported from Turkey. Mikrobiyol Bul 2013; 47: 708–716.
12. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005; 191: 1350–1360.
13. Mignogna MD, Fortuna G, Leuci S, Adamo D, Ruoppo E, Siano M, Mariani U. Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and critical review of the literature. Int J Infect Dis 2011; 15: 533–540.
14. Radner AB, Witt MD, Edwards JE Jr. Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review. Clin Infect Dis 1995; 20: 163–166.
15. Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R, Lortholary O, Petrikkos GL; European Conference on Infections in Leukemia. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 2013; 98: 492–504.
16. Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 2014; 20 (Suppl. 3): 5–26.
17. Ibrahim AS, Avanessian V, Spellberg B, Edwards JE Jr. Liposomal amphotericin B and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrob Agents Chemother 2003; 47: 3343–3344.
18. Vehreschild JJ, Birtel A, Vehreschild MJ, Liss B, Farowski F, Kochanek M, Sieniawski M, Wahlers F, Fatkenheuer G, Cornerly OA. Mucormycosis treated with posaconazole: a review of 96 case reports. Crit Rev Microbiol 2013; 39: 310–324.
19. Tedder M, Spratt JA, Anstad MP, Hedge SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994; 57: 1044–1050.
20. Vironneau P, Verillaud B, Tran H, Altabaa K, Blancal JP, Sauvaget E, Herman P, Kania R. Rhino-orbito-cerebral mucormycosis, surgical treatment, state of the art. Med Sci 2013; 29: 31–35.
21. Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, Ibrahim AS, Brass EP. Risk factors for mortality in patients with mucormycosis. Med Mycol 2012; 50: 611–618.
22. Petrikos G, Skiada A, Sambatakou H, Toskas A, Vaiopoulos G, Giannopoulou M, Katsilambros N. Mucormycosis: tenyear experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis 2003; 22: 753–756.
23. Petrikos G, Skiada A, Drogari-Apiranthitou M. Epidemiology of mucormycosis in Europe. Clin Microbiol Infect 2014; 20 (Suppl. 6): 67–73.
24. Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O; French Mycosis Study Group. A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007). Clin Infect Dis 2012; 54 (Suppl. 1): S35–S43.
25. Rüping MJ, Heinz WJ, Kindo AJ, Rickerts V, Lass-Förl C, Beisel C, Herbrecht R, Roth Y, Silling G, Ullmann AJ et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother 2010; 65: 296–302.